BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16094110)

  • 1. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial.
    Parikh AA; Scadding GK
    Laryngoscope; 2005 Aug; 115(8):1385-90. PubMed ID: 16094110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma.
    Ogata N; Darby Y; Scadding G
    J Laryngol Otol; 2007 Dec; 121(12):1156-60. PubMed ID: 17697437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical nasal lysine aspirin in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis.
    Parikh A; Scadding GK
    Expert Rev Clin Immunol; 2014 May; 10(5):657-65. PubMed ID: 24684687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acoustic rhinometry in the evaluation of intranasal aspirin challenge].
    Kupczyk M; Kupryś-Lipińska I; Bocheńska-Marciniak M; Kuna P
    Pneumonol Alergol Pol; 2010; 78(2):103-11. PubMed ID: 20306421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.
    Ragab S; Parikh A; Darby YC; Scadding GK
    Clin Exp Allergy; 2001 Sep; 31(9):1385-91. PubMed ID: 11591188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal lysine aspirin in recurrent nasal polyposis.
    Scadding GK; Hassab M; Darby YC; Lund VJ; Freedman A
    Clin Otolaryngol Allied Sci; 1995 Dec; 20(6):561-3. PubMed ID: 8665721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nasal provocation test with lysine-aspirin in diagnosis of nonallergic rhinitis with eosinophilia].
    Modrzyński M; Mazurek H; Zawisza E
    Otolaryngol Pol; 2006; 60(1):25-31. PubMed ID: 16821537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis.
    Patriarca G; Bellioni P; Nucera E; Schiavino D; Papa G; Schinco G; Fais G; Pirotta LR
    Ann Allergy; 1991 Dec; 67(6):588-92. PubMed ID: 1750721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical aspirin sensitivity in subjects with nasal polyposis.
    Killen JW; Wilson JA; Gibson GJ
    Clin Otolaryngol Allied Sci; 2003 Dec; 28(6):539-44. PubMed ID: 14616672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection.
    Corradini C; Del Ninno M; Buonomo A; Nucera E; Paludetti G; Alonzi C; Sabato V; Schiavino D; Patriarca G
    J Investig Allergol Clin Immunol; 2006; 16(3):188-93. PubMed ID: 16784013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
    Lee DK; Haggart K; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):185-8. PubMed ID: 15328680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
    Lee DK; Haggart K; Robb FM; Lipworth BJ
    Eur Respir J; 2004 Aug; 24(2):226-30. PubMed ID: 15332389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily.
    Rozsasi A; Polzehl D; Deutschle T; Smith E; Wiesmiller K; Riechelmann H; Keck T
    Allergy; 2008 Sep; 63(9):1228-34. PubMed ID: 18699939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of relapse in nasal polyposis.
    Patriarca G; Schiavino D; Nucera E; Papa G; Schinco G; Fais G
    Lancet; 1991 Jun; 337(8755):1488. PubMed ID: 1675359
    [No Abstract]   [Full Text] [Related]  

  • 15. Is a positive nasal lysine-aspirin challenge test associated with a more severe phenotype of chronic rhinosinusitis and asthma?
    Vaidyanathan S; Williamson PA; Lipworth BJ
    Am J Rhinol Allergy; 2012; 26(3):e89-93. PubMed ID: 22643934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do topical nasal decongestants affect polyps?
    Johansson L; Oberg D; Melén I; Bende M
    Acta Otolaryngol; 2006 Mar; 126(3):288-90. PubMed ID: 16618656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model.
    Kupczyk M; Antczak A; Kuprys-Lipinska I; Kuna P
    Allergy; 2009 Dec; 64(12):1746-52. PubMed ID: 19385948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of relapses of nasal polyposis with intranasal triamcinolone acetonide after polyp surgery: a prospective double-blind, placebo-controlled, randomised study with a 9-month follow-up.
    Vento SI; Blomgren K; Hytönen M; Simola M; Malmberg H
    Clin Otolaryngol; 2012 Apr; 37(2):117-23. PubMed ID: 22329774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
    Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nasal mucosal swelling and microcirculation throughout nasal and bronchial provocation tests with lysine-aspirin in asthmatics with nasal polyposis.
    Ehnhage A; Kölbeck KG; Juto JE; Dahlén B; Stjärne P
    Rhinology; 2010 Jun; 48(2):216-23. PubMed ID: 20502764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.